Can patients with an implanted brain chip (e.g., deep‑brain stimulator, responsive neurostimulation system, cortical interface) safely undergo MRI, and what conditions are required?

MRI Safety in Patients with Implanted Brain Devices

Patients with implanted brain devices (deep brain stimulators, responsive neurostimulation systems, cortical interfaces) can undergo MRI safely under specific conditions, but the device must be verified as "MRI conditional" and scanned according to manufacturer specifications—MRI is NOT generally contraindicated as previously believed.

Device Classification System

The most recent guidelines establish three critical safety categories for all implanted devices 1:

• "MRI unsafe" = absolute contraindication to MRI
• "MRI conditional" = relative contraindication; MRI permitted only under specific manufacturer-defined conditions
• "MRI safe" = no contraindication

Before scheduling any MRI, you must obtain the patient's implant pass and verify the device classification with the manufacturer (online resources available at https://mrisafety.com/) 1.

Key Safety Protocol

Pre-Imaging Requirements

1. Verify device specifications: Request implant documentation showing exact device type, model, location, and MRI compatibility status 1

2. For "MRI conditional" devices, obtain manufacturer guidelines specifying:

   • Maximum field strength allowed (typically 1.5T or 3T)
   • Specific absorption rate (SAR) limits
   • Required head coil positioning
   • Whether device must be turned off or reprogrammed

3. Multidisciplinary consultation: For cardiac rhythm management devices (pacemakers, ICDs), the 2005 ASA guidelines state MRI is "generally contraindicated" but can be performed with consultation between the ordering physician, cardiologist, diagnostic radiologist, and device manufacturer 2. This same collaborative approach applies to brain stimulation devices.

Evidence from Clinical Practice

Recent research demonstrates excellent safety when protocols are followed:

• 262 MRI examinations in 223 DBS patients showed only 1 temporary adverse event (patient agitation unrelated to device heating) 3

• 102 patients with active DBS systems underwent 1.5T and 3T MRI with zero short- or long-term adverse events when proper safety testing was performed 4

• Literature review of over 4,000 MRI examinations in DBS patients found only 4 adverse events total, with neurological deficits occurring only when safety protocols were violated 3

Critical Safety Considerations

Primary Risk: Electrode Tip Heating

The most serious risk remains radiofrequency-induced heating at electrode contacts, which can cause tissue damage 5. This is why:

• SAR limits must be strictly observed
• Continuous patient monitoring is essential
• Emergency protocols must be in place

Device-Specific Artifacts

Brain stimulation hardware creates predictable artifacts 4:

• Most prominent near electrode contacts (mean diameter 9.3 mm)
• Affects frontoparietal cortex where extension wires are coiled subcutaneously
• Only obscures 1.9% of total brain volume at 1.5T, 2.1% at 3.0T
• Artifacts are larger at 3T than 1.5T (P < .001)

Field Strength Selection

1.5T is generally preferred over 3T for patients with brain implants because:

• Smaller artifact footprint
• Lower heating risk
• More robust scanning sequences 6

When MRI is Clinically Necessary

Research shows 13% of DBS patients require imaging post-implantation, with younger patients more likely to need future MRI 7. Common indications include:

• Fall-related head trauma evaluation
• New neurological symptoms
• Tumor surveillance (9% of DBS patients in one series had tumor diagnoses) 7
• Surgical planning for unrelated conditions

For younger patients, strongly consider MRI-conditional devices at initial implantation to preserve future imaging access 7.

Practical Algorithm

1. Identify all device components (pulse generator, leads, extensions)—the most restrictive component determines MRI eligibility 8

2. If device is "MRI unsafe": MRI is contraindicated; use CT for emergent evaluation

3. If device is "MRI conditional":

   • Obtain complete manufacturer specifications
   • Coordinate with electrophysiology/neurosurgery team
   • Use 1.5T when possible
   • Monitor patient continuously during scan
   • Have emergency equipment immediately available

4. Document device interrogation before and after MRI to detect any parameter changes 2

Common Pitfalls to Avoid

• Never assume all components are compatible—a single "MRI unsafe" component makes the entire system unsafe 8
• Don't rely on outdated manufacturer guidelines—DBS vendor recommendations are inconsistent and evolving 3
• Avoid 3T when 1.5T is adequate—higher field strength increases both artifacts and heating risk 4
• Don't skip device interrogation—hardware failures, though rare, have been reported 3

The evidence strongly supports that with proper device verification and adherence to manufacturer protocols, MRI can be performed safely in most patients with brain implants 4, 5, 3. The key is rigorous pre-scan safety assessment rather than blanket contraindication.